Skip to main content
Clinical Trials/NCT04259827
NCT04259827
Unknown
Not Applicable

On-line Cognitive Training for Mild Cognitive Impairment in Parkinson's Disease: a Randomized Single-blind Study Using Wearing Sensors Technology

Università degli Studi di Brescia2 sites in 1 country60 target enrollmentOctober 15, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Università degli Studi di Brescia
Enrollment
60
Locations
2
Primary Endpoint
Trial making B performance, total score (0-240 seconds)
Last Updated
6 years ago

Overview

Brief Summary

Application of online cognitive training in patients affected by Parkinson's disease and mild cognitive impairment. The treatment consists of a 6-week on-line cognitive training preceded and followed by neurological, neuropsychological and motor assessment.

Detailed Description

At the recruitment, participants will undergo a neurological visit, a neuropsychology assessment (2 tests for each considered cognitive domain: memory, attention, visuospatial, executive function, language) and a motor assessment with wearing sensors under supervised conditions. In the treatment arm only, patients will have the Neuronation application installed on their personal technology device (smartphone or tablet) and are asked to complete 4 training session three times a week. Each session is composed of 5 exercises from one out of 4 cognitive domains: Memory, Attention, Speed and Reasoning. The training is tailor made, the complexity of the exercises is adjusted online, based on the patient's performance. Participants are re-assessed at the end of the 6-week cognitive training (T1) to find out its effects on cognition and motor ability. The same assessment is administered also after 1 (T2) and 3 (T3) months from the end of the cognitive training to test long-term effects.

Registry
clinicaltrials.gov
Start Date
October 15, 2019
End Date
February 10, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andrea Pilotto

Neurology Department Director

Università degli Studi di Brescia

Eligibility Criteria

Inclusion Criteria

  • Ease of use of at home internet connection
  • Active presence of a caregiver to help with the use of the App
  • Sufficient physical ability to use a technological device
  • Signature of informed consent

Exclusion Criteria

  • Presence of systemic pathologies potentially responsible for cognitive deficits
  • Presence of pathologies of the Central Nervous system potentially associated with cognitive deficits
  • No access to internet connection
  • Cognitive rehabilitation within the previous 6 months
  • Major depression (assessed by Beck Depression Inventory at baseline)

Outcomes

Primary Outcomes

Trial making B performance, total score (0-240 seconds)

Time Frame: Changes between baseline, immediately after the end of intervention, after 1 month and 3 months

Trial making B performance, total score (0-240 seconds)

Parkinson´s disease Quality of life questionnire (PDQ-39) (0-117 points)

Time Frame: Changes between baseline, immediately after the end of intervention, after 1 month and 3 months

PDQ-39 will be assessed in patients

Supervised gait performance dual task gait

Time Frame: Changes between baseline, immediately after the end of intervention, after 1 month and 3 months

Step variability using wearing sensors technology in one-minute supervised dual task walking

Sum of total Z-score of cognitive assessment (-30 to 30)

Time Frame: Changes between baseline, immediately after the end of intervention, after 1 month and 3 months

Sum of total Z-score of cognitive assessment (-30 to 30)

Supervised gait performance normal gait

Time Frame: Changes between baseline, immediately after the end of intervention, after 1 month and 3 months

Step variability using wearing sensors technology in one-minute supervised walking

Quality of life - caregivers

Time Frame: Changes between baseline, immediately after the end of intervention, after 1 month and 3 months

Caregiver Burden will be assessed with Dyadic relationship scale

Secondary Outcomes

  • Unified parkinson´s disease Rating Scale part 3 (0-132 points)(Changes between baseline, immediately after the end of intervention, after 1 month and 3 monthss)
  • Instability measures(Changes between baseline, immediately after the end of intervention, after 1 month and 3 months)
  • Turning performances(Changes between baseline, immediately after the end of intervention, after 1 month and 3 months)
  • Dual task performance in circular walking (0-240 seconds)(Changes between baseline, immediately after the end of intervention, after 1 month and 3 months)
  • Short Physical performance battery (SPPB), total time (0- 60 seconds)(Changes between baseline, immediately after the end of intervention, after 1 month and 3 months)

Study Sites (2)

Loading locations...

Similar Trials